https://www.thebodypro.com/author/sean-r-hosein
Sean Hosein

Sean R. Hosein

Sean R. Hosein is the science and medical editor of CATIE, a prominent Canadian HIV news and information resource. He has been covering HIV news since 1988. CATIE profiled Hostein in 2014 for its landmark 200th TreatmentUpdate issue.

Latest by Sean R. Hosein

man working alone in office

Loneliness Linked to Poorer Brain Health and Reduced Quality of Life in HIV

As CATIE reports, a Canadian study found that people living with HIV were more likely to be lonely than the average person—and that loneliness grew more common the younger a person with HIV was.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange
Undetectable = Untransmittable -- CATIE Signs On Img
News Analysis

Factors Associated With Hepatitis C Infection Among Men Who Take PrEP

IPERGAY scientists recommended that clinicians screen patients who request PrEP, as well as patients who are already using it, for a number of key HCV risk factors.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange
Undetectable = Untransmittable -- CATIE Signs On Img
News

Montreal Researchers Explore Cannabis Use Among People With HIV and Hepatitis C

Montreal scientists found that 88% of cannabis users had an undetectable viral load. This suggests that a very large majority of cannabis users did not have problems adhering to antiretroviral therapy.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange
doctor looking at list talking to patient
News Analysis

British Columbia Study Finds That Providing ART and Methadone in the Same Facility Helps Adherence

The scientists noted that daily ingestion of methadone provides an opportunity to supervise the consumption of HIV medications in places where methadone is dispensed.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange
hepatitis word cloud
News Analysis

Trends in Deaths Among People With Hepatitis C Virus in British Columbia

A new study puts numbers to increasingly divergent trends in liver-related deaths vs. injection-related deaths in recent years, highlighting both the success of modern HCV treatment and the devastating effects of the opioid crisis.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange
Overdoses and Smoking Are Taking the Lives of People With HIV Who Have Been Cured of Hepatitis C Img
Hepatitis C

Overdoses and Smoking Are Taking the Lives of People With HIV Who Have Been Cured of Hepatitis C

"Providing HCV treatment alone while neglecting to concurrently address the social determinants of health will do little to improve the health outcomes of the majority of individuals with chronic HCV," the study authors wrote.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange
Large French Study Examines Neuropsychiatric Side Effects With Integrase Inhibitors Img
Neurocognitive

Large French Study Examines Neuropsychiatric Side Effects With Integrase Inhibitors

This will likely become the landmark study about the overall rate of neuropsychiatric side effects with this class of medicines over the next several years.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange
De-Simplifying Single-Tablet Regimens for HIV Treatment Img

De-Simplifying Single-Tablet Regimens for HIV Treatment

A Canadian study of this cost-saving approach found high acceptance of de-simplification among people already on a single-tablet regimen, and even higher rates among people who were just initiating single-tablet treatment.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange
Dual Maintenance Therapy With Dolutegravir + Rilpivirine Img
News Analysis

Dual Maintenance Therapy With Dolutegravir + Rilpivirine

In clinical trials called Sword 1 and Sword 2, researchers testing a combination of dolutegravir/rilpivirine (Juluca) found it to be effective and tolerable.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange
Monkey Study Uncovers the Potential for Vesatolimod and Antibodies in HIV Cure Research Img

Monkey Study Uncovers the Potential for Vesatolimod and Antibodies in HIV Cure Research

Researchers hope that by interacting with the toll-like receptor protein TLR-7 an experimental drug can help increase the immune system's ability to sense and attack HIV and HIV-infected cells.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange